BRIEF-Novonesis Says Outlook For FY Adjusted EBITDA Margin Is Now 37-38%

Aug 19 (Reuters) – Novozymes A/S: * NOVONESIS OUTLOOK FY ADJUSTED EBITDA MARGIN 37-38% * NOVONESIS – NOVONESIS RAISES FY2026 ORGANIC SALES GROWTH OUTLOOK TO 7-8% FROM 5-7% Source text: Further company

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)